Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide

Por Wallis, Robert S., Jakubiec, Wesley, Mitton-Fry, Mark, Ladutko, Lynn, Campbell, Sheldon, Paige, Darcy, Silvia, Annette, Miller, Paul F.
Publicado em 2012

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

Por Wallis, Robert S., Jakubiec, Wesley, Kumar, Vikas, Bedarida, Gabriella, Silvia, Annette, Paige, Darcy, Zhu, Tong, Mitton-Fry, Mark, Ladutko, Lynn, Campbell, Sheldon, Miller, Paul F.
Publicado em 2011

Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

Por Wallis, Robert S., Dawson, Rodney, Friedrich, Sven O., Venter, Amour, Paige, Darcy, Zhu, Tong, Silvia, Annette, Gobey, Jason, Ellery, Craig, Zhang, Yao, Eisenach, Kathleen, Miller, Paul, Diacon, Andreas H.
Publicado em 2014